Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00712114 · ClinicalTrials.gov registry record · Phase 1

Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis

A Phase 1 study of Rheumatoid Arthritis, sponsored by Harbor Therapeutics.

Completed
Registry status
Phase 1
Development phase
14
Enrollment target
1
Study location

NCT00712114 is a Phase 1 study of Rheumatoid Arthritis that has completed, run by Harbor Therapeutics. The registered enrollment target is 14 participants, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00712114, a Phase 1 study of Rheumatoid Arthritis, has completed, sponsored by Harbor Therapeutics.

COMPLETED
Registry status
Phase 1
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot, exploratory study is to evaluate the safety, tolerance, pharmacokinetics and potential anti-inflammatory activity of an investigational agent, HE3286, when administered orally for 29 days to patients with rheumatoid arthritis that are taking a stable dose of methotrexate.

Conditions Studied

Rheumatoid Arthritis

Interventions

  • DRUG HE3286

Study Locations (1)

California

  • - Beverly Hills

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2008-07
Est. Completion 2009-07
Phase Phase 1

Sponsor

Harbor Therapeutics

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00712114

The ClinicalTrials.gov registry entry for NCT00712114 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,691-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (100% lower). The listed sponsor is Harbor Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which HE3286 is the first listed.

NCT00712114 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00712114 about?

NCT00712114 is a clinical study titled "Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis". The purpose of this pilot, exploratory study is to evaluate the safety, tolerance, pharmacokinetics and potential anti-inflammatory activity of an investigational agent, HE3286, when administered orally for 29 days to patients with rheumatoid arthritis that are taking a stable dose of methotrexate.

What is the current status of trial NCT00712114?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2008-07. Estimated completion is 2009-07.

What conditions does trial NCT00712114 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT00712114?

The interventions under investigation include: HE3286 (DRUG).

Who is sponsoring clinical trial NCT00712114?

This trial is sponsored by Harbor Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00712114 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.